Searched for
ACQUIRE BRANDS
M3M Group to invest Rs 10,000 cr on construction, land acquisition in FY27- Legacy studios bet on mobile-first entertainment for next growth phaseIndia's established media giants like Yash Raj Films, Zee Entertainment, and Saregama are strategically investing in digital-first platform...
- Oyo parent files updated DRHP for Rs 6,650 crore IPO: Key things to knowOyo's parent company, Prism, has filed for a Rs 6,650 crore IPO, with plans for a potential pre-IPO placement. The bulk of the funds will b...
- PRISM files IPO papers for Rs 6650 crore fresh issue, reports Rs 748 crore profit in 9MFY26Oyo's parent company, PRISM, has filed its IPO papers with SEBI, planning a Rs 6,650 crore fresh issue to repay borrowings. The hospitality...
- Quote of the day by Estée Lauder: 'I never dreamed about success. I worked...' - cosmetics company Estée Lauder Companies' co-founder teaches life lesson on why hard work is the key to successQuote of the day by Estée Lauder: Estée Lauder's life story underscores that success isn't born from dreams alone, but forged through relen...
- Rocket Lab buys Iridium in $8 billion deal, to expand beyond launchesThe deal accelerates a long-time push beyond launch services by adding an established satellite network, globally coordinated spectrum and ...
- ITC's business with BAT grows 10% to Rs 1,587 crore in FY26, but dividend payout falls 9%ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...
- Two British American Tobacco-linked entities receive Rs 3,896 crore ITC dividend in FY26British American Tobacco's Indian entities received ₹3,895.74 crore in dividends from ITC in FY26, a slight decrease from the previous year...
- Cold war over ice cream: A three-decade old Vadilal family feud returns to Bombay High CourtA three-decade-old family pact dividing the Vadilal ice cream brand is now a legal battleground. The Mumbai branch has sued the Ahmedabad b...
- Quote of the day by iconic Donatella Versace: ‘Die and born again, die and born again. It's the…’ – Italian designer on reinvention and rising after every fallLife's inevitable setbacks, from career stumbles to personal loss, can feel like endings. However, fashion icon Donatella Versace's quote, ...
- Womenswear retailer Reformation reports revenue rise in US IPO filingSustainable fashion brand Reformation has filed for a U.S. IPO, reporting a revenue increase to $507.1 million for the year ending December...
- HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 croreHDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder...
- Noel exiting Trent: The quiet Tata who built a loud success storyNoel Tata reportedly told shareholders at Trent's annual general meeting that it would be his last as chairman, signalling the close of a t...
- EMA Partners India acquires digital RPO services provider Taggd in Rs 95 crore all-cash dealEMA Partners India has acquired Taggd, a digital RPO provider, for Rs 95 crore in an all-cash deal. This strategic move integrates executiv...
- Why Meta tapped Kunal Shah; Beauty’s new factory boomHappy Wednesday! Meta just handed WhatsApp’s steering wheel to Cred’s Kunal Shah, betting he can turn India’s favourite chat app into a pay...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Dealmaking stays strong as startup M&A momentum carries into 2026Indian startups are experiencing a surge in M&A exits, particularly in consumer, fintech, and ecommerce sectors, signalling a robust recove...
Load More
